These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37859722)

  • 1. Screening and optimization of phage display cyclic peptides against the WDR5 WBM site.
    Song L; Cao J; Chen L; Du Z; Zhang N; Cao D; Xiong B
    RSC Med Chem; 2023 Oct; 14(10):2048-2057. PubMed ID: 37859722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5.
    Cao J; Fan T; Li Y; Du Z; Chen L; Wang Y; Wang X; Shen J; Huang X; Xiong B; Cao D
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33668971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma.
    Han QL; Zhang XL; Ren PX; Mei LH; Lin WH; Wang L; Cao Y; Li K; Bai F
    Acta Pharmacol Sin; 2023 Apr; 44(4):877-887. PubMed ID: 36207403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction.
    Ding J; Li G; Liu H; Liu L; Lin Y; Gao J; Zhou G; Shen L; Zhao M; Yu Y; Guo W; Hommel U; Ottl J; Blank J; Aubin N; Wei Y; He H; Sage DR; Atadja PW; Li E; Jain RK; Tallarico JA; Canham SM; Chiang YL; Wang H
    ACS Chem Biol; 2023 Jan; 18(1):34-40. PubMed ID: 36594833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule WDR5 inhibitors down-regulate lncRNA expression.
    Chang JY; Neugebauer C; Mues Genannt Koers A; 't Hart P
    RSC Med Chem; 2024 Feb; 15(2):636-640. PubMed ID: 38389889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction.
    Ding J; Liu L; Chiang YL; Zhao M; Liu H; Yang F; Shen L; Lin Y; Deng H; Gao J; Sage DR; West L; Llamas LA; Hao X; Kawatkar S; Li E; Jain RK; Tallarico JA; Canham SM; Wang H
    J Med Chem; 2023 Jun; 66(12):8310-8323. PubMed ID: 37307526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders.
    Gurung R; Om D; Pun R; Hyun S; Shin D
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping characteristics of weak interactions of two transcriptional regulators with WDR5.
    Ahmad M; Imran A; Movileanu L
    Int J Biol Macromol; 2024 Feb; 258(Pt 2):128969. PubMed ID: 38158065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of WIN site inhibitor on the WDR5 interactome.
    Guarnaccia AD; Rose KL; Wang J; Zhao B; Popay TM; Wang CE; Guerrazzi K; Hill S; Woodley CM; Hansen TJ; Lorey SL; Shaw JG; Payne WG; Weissmiller AM; Olejniczak ET; Fesik SW; Liu Q; Tansey WP
    Cell Rep; 2021 Jan; 34(3):108636. PubMed ID: 33472061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Selection of Cyclic Peptides for Application in Research and Drug Development.
    Deyle K; Kong XD; Heinis C
    Acc Chem Res; 2017 Aug; 50(8):1866-1874. PubMed ID: 28719188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors.
    Teuscher KB; Mills JJ; Tian J; Han C; Meyers KM; Sai J; South TM; Crow MM; Van Meveren M; Sensintaffar JL; Zhao B; Amporndanai K; Moore WJ; Stott GM; Tansey WP; Lee T; Fesik SW
    J Med Chem; 2023 Dec; 66(24):16783-16806. PubMed ID: 38085679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.
    Bakhshinejad B; Zade HM; Shekarabi HS; Neman S
    Amino Acids; 2016 Dec; 48(12):2699-2716. PubMed ID: 27650972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.
    Teuscher KB; Meyers KM; Wei Q; Mills JJ; Tian J; Alvarado J; Sai J; Van Meveren M; South TM; Rietz TA; Zhao B; Moore WJ; Stott GM; Tansey WP; Lee T; Fesik SW
    J Med Chem; 2022 Apr; 65(8):6287-6312. PubMed ID: 35436124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach.
    Qin S; Feng L; Zhao Q; Yan Z; Lyu X; Li K; Mu B; Chen Y; Lu W; Wang C; Suo Y; Yue J; Cui M; Li Y; Zhao Y; Duan Z; Zhu J; Lu X
    J Med Chem; 2024 Jan; 67(2):1079-1092. PubMed ID: 38166388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment screening for a protein-protein interaction inhibitor to WDR5.
    Dennis ML; Morrow BJ; Dolezal O; Cuzzupe AN; Stupple AE; Newman J; Bentley J; Hattarki M; Nuttall SD; Foitzik RC; Street IP; Stupple PA; Monahan BJ; Peat TS
    Struct Dyn; 2019 Nov; 6(6):064701. PubMed ID: 31768400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity.
    Aho ER; Wang J; Gogliotti RD; Howard GC; Phan J; Acharya P; Macdonald JD; Cheng K; Lorey SL; Lu B; Wenzel S; Foshage AM; Alvarado J; Wang F; Shaw JG; Zhao B; Weissmiller AM; Thomas LR; Vakoc CR; Hall MD; Hiebert SW; Liu Q; Stauffer SR; Fesik SW; Tansey WP
    Cell Rep; 2019 Mar; 26(11):2916-2928.e13. PubMed ID: 30865883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library.
    Sahin D; Taflan SO; Yartas G; Ashktorab H; Smoot DT
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):927-932. PubMed ID: 29693344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities.
    Giebel LB; Cass RT; Milligan DL; Young DC; Arze R; Johnson CR
    Biochemistry; 1995 Nov; 34(47):15430-5. PubMed ID: 7492543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR-driven cell lines.
    Jiwacharoenchai N; Tabtimmai L; Kiriwan D; Suwattanasophon C; Seetaha S; Sinthuvanich C; Choowongkomon K
    J Cell Biochem; 2022 Feb; 123(2):248-258. PubMed ID: 34633106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.
    Ye X; Zhang R; Lian F; Zhang W; Lu W; Han J; Zhang N; Jin J; Luo C; Chen K; Ye F; Ding H
    Bioorg Med Chem Lett; 2019 Feb; 29(4):638-645. PubMed ID: 30626558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.